Apoferritin improves motor deficits in MPTP-treated mice by regulating brain iron metabolism and ferroptosis
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Apoferritin improves motor deficits in MPTP-treated mice by regulating brain iron metabolism and ferroptosis
Authors
Keywords
-
Journal
iScience
Volume 24, Issue 5, Pages 102431
Publisher
Elsevier BV
Online
2021-04-19
DOI
10.1016/j.isci.2021.102431
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Analysis of DNA methylation associates the cystine–glutamate antiporter SLC7A11 with risk of Parkinson’s disease
- (2020) Costanza L. Vallerga et al. Nature Communications
- Ferroptosis and its potential role in the physiopathology of Parkinson’s Disease
- (2020) Laura Mahoney-Sánchez et al. PROGRESS IN NEUROBIOLOGY
- Iron deposition in Parkinson’s disease by quantitative susceptibility mapping
- (2019) Qiqi Chen et al. BMC NEUROSCIENCE
- Ventral posterior substantia nigra iron increases over 3 years in Parkinson's disease
- (2019) Niels Bergsland et al. MOVEMENT DISORDERS
- The Association of Iron and the Pathologies of Parkinson’s Diseases in MPTP/MPP+-Induced Neuronal Degeneration in Non-human Primates and in Cell Culture
- (2019) Liangqin Shi et al. Frontiers in Aging Neuroscience
- FSP1 is a glutathione-independent ferroptosis suppressor
- (2019) Sebastian Doll et al. NATURE
- The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis
- (2019) Kirill Bersuker et al. NATURE
- The role of iron in Parkinson's disease monkeys assessed by susceptibility weighted imaging and inductively coupled plasma mass spectrometry
- (2019) Shao-Jun Li et al. LIFE SCIENCES
- ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition
- (2016) Sebastian Doll et al. Nature Chemical Biology
- Ferroptosis, a newly characterized form of cell death in Parkinson's disease that is regulated by PKC
- (2016) Bruce Do Van et al. NEUROBIOLOGY OF DISEASE
- Highly specific changes in antioxidant levels and lipid peroxidation in Parkinson’s disease and its progression: Disease and staging biomarkers and new drug targets
- (2016) Carine Coneglian de Farias et al. NEUROSCIENCE LETTERS
- Ferritin nanocages: A biological platform for drug delivery, imaging and theranostics in cancer
- (2016) Marta Truffi et al. PHARMACOLOGICAL RESEARCH
- Magnetic Resonance Imaging Features of the Nigrostriatal System: Biomarkers of Parkinson’s Disease Stages?
- (2016) Lucie Hopes et al. PLoS One
- T cell lipid peroxidation induces ferroptosis and prevents immunity to infection
- (2015) Mai Matsushita et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Is the 1254T>C polymorphism in the DMT1 gene associated with Parkinson’s disease?
- (2015) Selva Moheb Saadat et al. NEUROSCIENCE LETTERS
- Regulation of Ferroptotic Cancer Cell Death by GPX4
- (2014) Wan Seok Yang et al. CELL
- Targeting dysregulation of brain iron homeostasis in Parkinson's disease by iron chelators
- (2013) Orly Weinreb et al. FREE RADICAL BIOLOGY AND MEDICINE
- The role of iron and reactive oxygen species in cell death
- (2013) Scott J Dixon et al. Nature Chemical Biology
- The dopamine metabolite aminochrome inhibits mitochondrial complex I and modifies the expression of iron transporters DMT1 and FPN1
- (2012) Pabla Aguirre et al. BIOMETALS
- Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death
- (2012) Scott J. Dixon et al. CELL
- Magnetoferritin nanoparticles for targeting and visualizing tumour tissues
- (2012) Kelong Fan et al. Nature Nanotechnology
- Regulation of cellular iron metabolism
- (2011) Jian Wang et al. BIOCHEMICAL JOURNAL
- Glutathione Peroxidase 4 is associated with Neuromelanin in Substantia Nigra and Dystrophic Axons in Putamen of Parkinson's brain
- (2011) Frederick P Bellinger et al. Molecular Neurodegeneration
- Two to Tango: Regulation of Mammalian Iron Metabolism
- (2010) Matthias W. Hentze et al. CELL
- Astaxanthin protects against MPTP/MPP+-induced mitochondrial dysfunction and ROS production in vivo and in vitro
- (2010) Dae-Hee Lee et al. FOOD AND CHEMICAL TOXICOLOGY
- Native and synthetic ferritins for nanobiomedical applications: recent advances and new perspectives
- (2010) José M Domínguez-Vera et al. Future Medicinal Chemistry
- Increased Iron in the Substantia Nigra Compacta of the MPTP-Lesioned Hemiparkinsonian African Green Monkey: Evidence from Proton Microprobe Elemental Microanalysis
- (2010) J. A. Temlett et al. JOURNAL OF NEUROCHEMISTRY
- Iron and reactive oxygen species activity in parkinsonian substantia nigra
- (2010) Anna Wypijewska et al. PARKINSONISM & RELATED DISORDERS
- Iron transport in Parkinson's disease
- (2009) E.C. Hirsch PARKINSONISM & RELATED DISORDERS
- Up-regulation of divalent metal transporter 1 is involved in 1-methyl-4-phenylpyridinium (MPP+)-induced apoptosis in MES23.5 cells
- (2008) Shuzhen Zhang et al. NEUROBIOLOGY OF AGING
- Divalent metal transporter 1 (DMT1) contributes to neurodegeneration in animal models of Parkinson's disease
- (2008) J. Salazar et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started